---
document_datetime: 2023-09-21 17:21:11
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/tybost-epar-all-authorised-presentations_en.pdf
document_name: tybost-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6957097
conversion_datetime: 2025-12-23 05:47:50.521927
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU number       | (Invented) name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate packaging   | Pack size                       |
|-----------------|-------------------|------------|-----------------------|---------------------------|-----------------------|---------------------------------|
| EU/1/13/872/001 | Tybost            | 150 mg     | Film-coated tablet    | Oral use                  | bottle (HDPE)         | 30 tablets                      |
| EU/1/13/872/002 | Tybost            | 150 mg     | Film-coated tablet    | Oral use                  | bottle (HDPE)         | 90 (3 x 30) tablets (multipack) |